Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Biphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09
Harman MS et al. – Regularly ovulating women of reproductive age are significantly protected against CVD compared with men, but CVD increases within 10 years of menopause to levels matching or exceeding incidence rates among men,13 suggesting that ovarian estrogen may help protect women against atherosclerosis. This observation led to the corollary hypothesis that treatment of postmenopausal women with estrogens (menopausal hormone therapy [MHT]) might prevent the postmenopausal increase in CVD rates. Yet, despite more than 30 years of research attempting to define whether and how postmenopausal estrogen replacement might protect women against CVD, the issue remains uncertain and, indeed, controversial.
Related Articles
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Women's Health, 11/02/09
Relevance Score: 96%
Changes in Postmenopausal Hormone Replacement Therapy Use Among Women with High Cardiovascular Risk
American Journal of Public Health, 10/19/09
Relevance Score: 93%
Hormone replacement therapy benefits postmenopausal women
Internet Source, 10/09/09
Relevance Score: 93%
Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women
Atherosclerosis, 11/13/09
Relevance Score: 88%
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
EurekAlert, 10/29/09
Relevance Score: 88%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationships of BMI to Cardiovascular Risk Factors Differ by Ethnicity
Obesity, 11/20/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/20/09
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


